Zymeworks Inc.
ZYME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $76 | $76 | $412 | $27 |
| % Growth | 0.4% | -81.6% | 1,446% | – |
| Cost of Goods Sold | $0 | $143 | $0 | $0 |
| Gross Profit | $76 | -$67 | $412 | $27 |
| % Margin | 100% | -88.1% | 100% | 100% |
| R&D Expenses | $135 | $144 | $209 | $200 |
| G&A Expenses | $62 | $70 | $73 | $43 |
| SG&A Expenses | $62 | $70 | $73 | $43 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $17 | -$143 | -$0 | -$0 |
| Operating Expenses | $213 | $71 | $282 | $242 |
| Operating Income | -$137 | -$138 | $131 | -$216 |
| % Margin | -179.7% | -181.6% | 31.6% | -808.2% |
| Other Income/Exp. Net | $20 | $19 | $5 | $3 |
| Pre-Tax Income | -$117 | -$119 | $135 | -$212 |
| Tax Expense | $6 | -$1 | $11 | -$1 |
| Net Income | -$123 | -$119 | $124 | -$212 |
| % Margin | -160.8% | -156.1% | 30.1% | -794% |
| EPS | -1.62 | -1.72 | 1.91 | -4.06 |
| % Growth | 5.8% | -190.1% | 147% | – |
| EPS Diluted | -1.62 | -1.72 | 1.9 | -4.06 |
| Weighted Avg Shares Out | 76 | 69 | 65 | 52 |
| Weighted Avg Shares Out Dil | 76 | 69 | 65 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $20 | $4 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $11 | $17 | $12 | $10 |
| EBITDA | -$109 | -$121 | $142 | -$206 |
| % Margin | -142.4% | -158.8% | 34.5% | -772.4% |